|
|
eLetters is an online forum for ongoing
peer review. To submit an eLetter please go to the article you wish
to respond to and click on the link that reads
"eLetters: Submit a Response." Submission of
eLetters are open to all health care professionals
and experts in related fields.
eLetters to:
-
- STATE-OF-THE-ART REVIEW ARTICLE:
Madhusmita Misra, Danièle Pacaud, Anna Petryk, Paulo Ferrez Collett-Solberg, Michael Kappy on behalf of the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society
- Vitamin D Deficiency in Children and Its Management: Review of Current Knowledge and Recommendations
Pediatrics 2008; 122: 398-417
[Abstract]
[Full text]
[PDF]
|
|
eLetters published:
-
Hypocalcemia due to vitamin D deficiency: is calcitriol treatment really required?
- Giampiero I. Baroncelli, Silvano Bertelloni, Francesco Vierucci
(19 March 2009)
-
Hypocalcemia due to vitamin D deficiency: is calcitriol treatment really required?
- Giampiero I. Baroncelli, Silvano Bertelloni, Francesco Vierucci
(23 April 2009)
|
Hypocalcemia due to vitamin D deficiency: is calcitriol treatment really required? |
19 March 2009 |
|
|
Giampiero I. Baroncelli, Pediatrician Department of Pediatrics, S. Chiara University Hospital Pisa, Italy, Silvano Bertelloni, Francesco Vierucci
Send letter to journal:
Re: Hypocalcemia due to vitamin D deficiency: is calcitriol treatment really required?
g.baroncelli{at}med.unipi.it Giampiero I. Baroncelli, et al.
|
To the Editor:
We read with great interest the review article in Pediatrics by Misra
et al. (1) on the management and treatment of vitamin D deficiency. The
authors reported that simptomatic hypocalcemia with tetany or convulsions
should be treated with i.v. 10% calcium gluconate associated, if
necessary, with calcitriol until serum calcium levels normalize.
Recently, a 10-month-old boy with generalized seizure (duration
approximately 3 minutes) with normal temperature was adimitted to our
hospital. Clinical examination showed a large anterior fontanelle, frontal
bossing with no dysmorphic features, craniotabes, and hypotonia.
Laboratory results revealed severe hypocalcemia (4.3 mg/dL),
hypophosphatemia (3.1 mg/dL), increased alkaline phosphatase (2031 U/L;
normal values 80-645 U/L), parathyroid hormone (189 pg/mL, normal values
10-65 pg/mL), and 1,25-dihydroxyvitamin D (181.8 pg/mL; normal values 20-
80 pg/mL) levels, and reduced 25-hydroxyvitamin D levels (12.8 ng/mL;
"desiderable levels" > 20 ng/mL) (2). The child had immigrated to Italy
from North Africa, and he was exclusivey breast-fed with no vitamin D
supplementation. Radiographs of wrist and knee confirmed vitamin D
deficiency rickets. The administration of i.v. 10% calcium gluconate
followed by oral calcium as carbonate associated with cholecalciferol
treatment (5000 IU per day) quickly restored normocalcemia (Table). After
nine days of treament, parathyroid hormone and 25-hydroxyvitamin D levels
normalize (31.4 pg/mL and 50.7 ng/mL, respectively).
In our opinion, vitamin D metabolites, such as calcitriol, should be
used if a defect in vitamin D metabolism or an hypoparathyroid state is
present; their use in vitamin D deficiency rickets may be a medical error
(3, 4). Our data clearly showed the efficacy of cholecalciferol in
restoring normocalcemia and a normal vitamin D status. In fact, as also
suggested by Holick (4), calcitriol enhances the 25-hydroxyvitamin D-24-
hydroxylase (CYP24R) activity with increased degradation of both 25-
hydroxyvitamin D and 1,25-dihydroxyvitamin D.
Therefore, cholecalciferol treatment is efficacious and cost-
effective to normalize hypocalcemia due to vitamin D deficiency, and there
is not a clear indication to the use of calcitriol in this form of
rickets.
Giampiero Igli Baroncelli, M.D.
Department of Pediatrics, S. Chiara University Hospital
Via Roma, 67
56126 Pisa, Italy
g.baroncelli@med.unipi.it
Silvano Bertelloni, M.D.
Department of Pediatrics, S. Chiara University Hospital
Via Roma, 67
56126 Pisa, Italy
Francesco Vierucci, M.D.
Department of Pediatrics, S. Chiara University Hospital
Via Roma, 67
56126 Pisa, Italy
References
1.Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M; Drug and
Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society.
Vitamin D deficiency in children and its management: review of current
knowledge and recommendations. Pediatrics. 2008;122(2):398417
2.Wagner CL, Greer FR; American Academy of Pediatrics Section on
Breastfeeding; American Academy of Pediatrics Committee on Nutrition.
Prevention of rickets and vitamin D deficiency in infants, children, and
adolescents. Pediatrics. 2008;122(5):11421152
3.Wharton B, Bishop N. Rickets. Lancet.
2003;362(9393):13891400
4.Holick MF. Vitamin D deficiency. N Engl J Med.
2007;357(3):266281
Table. Serum calcium levels at admission and during treatment in the
patient.
At admission 24 h 48 h 72 h
Calcium levels, mg/dL 4.3 6.8 7.6 8.6
i.v. 10% calcium gluconate* 1440 1250 960 -
Oral calcium as carbonate* - - 500 1000
Oral cholecalciferol° - 5000 5000 5000
*Expressed as elemental calcium, mg per day; °IU per day.
Conflict of Interest:
None declared |
|
Hypocalcemia due to vitamin D deficiency: is calcitriol treatment really required? |
23 April 2009 |
|
|
Giampiero I. Baroncelli, Pediatrician Department of Pediatrics, S. Chiara University Hospital, Pisa, Italy, Silvano Bertelloni, Francesco Vierucci
Send letter to journal:
Re: Hypocalcemia due to vitamin D deficiency: is calcitriol treatment really required?
g.baroncelli{at}med.unipi.it Giampiero I. Baroncelli, et al.
|
To the Editor:
We read with great interest the review article in Pediatrics by Misra
et al. (1) on the management and treatment of vitamin D deficiency. The
authors reported that simptomatic hypocalcemia with tetany or convulsions
should be treated with i.v. 10% calcium gluconate associated, if
necessary, with calcitriol until serum calcium levels normalize.
Recently, a 10-month-old boy with generalized seizure (duration
approximately 3 minutes) with normal temperature was admitted to our
hospital. Clinical examination showed a large anterior fontanelle, frontal
bossing with no dysmorphic features, craniotabes, and hypotonia.
Laboratory results revealed severe hypocalcemia (4.3 mg/dL),
hypophosphatemia (3.1 mg/dL), increased alkaline phosphatase (2031 U/L;
normal values 80-645 U/L), parathyroid hormone (189 pg/mL, normal values
10-65 pg/mL), and 1,25-dihydroxyvitamin D (181.8 pg/mL; normal values 20-
80 pg/mL) levels, and reduced 25-hydroxyvitamin D levels (12.8 ng/mL;
"desiderable levels" > 20 ng/mL) (2). The child had immigrated to Italy
from North Africa, and he was exclusivey breast-fed with no vitamin D
supplementation. Radiographs of wrist and knee confirmed vitamin D
deficiency rickets. The administration of i.v. 10% calcium gluconate (at
admission, 1440 mg; 24h, 1250 mg; 48h, 960 mg; expressed as elemental
calcium per day) followed by oral calcium as carbonate (48h, 500 mg; 72h,
1000 mg; expressed as elemental calcium per day) associated with
cholecalciferol treatment (5000 IU per day, started from 24h) quickly
restored normocalcemia (24h, 6.8 mg/dL; 48h, 7.6 mg/dL; 72h, 8.6 mg/dL).
After nine days of treament, parathyroid hormone and 25-hydroxyvitamin D
levels normalize (31.4 pg/mL and 50.7 ng/mL, respectively).
In our opinion, vitamin D metabolites, such as calcitriol, should be
used if a defect in vitamin D metabolism or an hypoparathyroid state is
present; their use in vitamin D deficiency rickets may be a medical error
(3, 4). Our data clearly showed the efficacy of cholecalciferol in
restoring normocalcemia and a normal vitamin D status. In fact, as also
suggested by Holick (4), calcitriol enhances the 25-hydroxyvitamin D-24-
hydroxylase (CYP24R) activity with increased degradation of both 25-
hydroxyvitamin D and 1,25-dihydroxyvitamin D.
Therefore, cholecalciferol treatment is efficacious and cost-
effective to normalize hypocalcemia due to vitamin D deficiency, and there
is not a clear indication to the use of calcitriol in this form of
rickets.
Giampiero Igli Baroncelli, M.D.
Department of Pediatrics, S. Chiara University Hospital
Via Roma, 67
56126 Pisa, Italy
g.baroncelli@med.unipi.it
Silvano Bertelloni, M.D.
Department of Pediatrics, S. Chiara University Hospital
Via Roma, 67
56126 Pisa, Italy
Francesco Vierucci, M.D.
Department of Pediatrics, S. Chiara University Hospital
Via Roma, 67
56126 Pisa, Italy
References
1.Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M; Drug and
Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society.
Vitamin D deficiency in children and its management: review of current
knowledge and recommendations. Pediatrics. 2008;122(2):398-417
2.Wagner CL, Greer FR; American Academy of Pediatrics Section on
Breastfeeding; American Academy of Pediatrics Committee on Nutrition.
Prevention of rickets and vitamin D deficiency in infants, children, and
adolescents. Pediatrics. 2008;122(5):1142-1152
3.Wharton B, Bishop N. Rickets. Lancet. 2003;362(9393):1389-1400
4.Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-281
Conflict of Interest:
None declared |
| |
|